one of the world’s largest clinical research organizations, will provide a variety of services to the .

PPD (Nasdaq: PPDI), which is based in Wilmington and has a large operation in the Research Triangle Park area, will work with researchers conducting early phase clinical trials in type 1 diabetes research projects that are funded by the diabetes group, the company said.

Financial terms were not disclosed.

The JDRF funded $156 million in research across 22 countries in 2007.

Lisa Hornick, PPD’s chief medical officer, and Randy Anderson, vice president of development,  will work with the association on projects.

PPD, a longtime supporter of the JDRF, will assist in reviewing clinical development proposals, designing clinical trials and helping to carry out some trials.

The JDRF is the world’s largest charitable organization focused on type 1 diabetes research. Launched in 1970, it has funded more than $1.3 billion in research.

“As many as 3 million Americans may have type 1 diabetes, an autoimmune disease that impacts both children and adults,” Anderson said in a statement. “We are pleased and honored to partner with JDRF to help speed development of curative therapies for this debilitating disease, which can have devastating complications like kidney failure, blindness, heart disease, stroke and amputation.”